Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis

Isabela A.G. Pereira, Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage, Fernanda F. Ramos, João A. Oliveira-da-Silva, Luciana M.R. Antinarelli, Amanda S. Machado, Lívia M. Carvalho, Ana Maria R.S. Carvalho, Iorrana V. Salustiano, Thiago A.R. Reis, Raquel S. Bandeira, Alessandra M. Silva, Vívian T. Martins, Miguel A. Chávez-Fumagalli, Maria V. Humbert, Bruno M. Roatt, Mariana C. Duarte, Daniel Menezes-SouzaElaine S. Coimbra, João Paulo V. Leite, Eduardo A.F. Coelho, Denise U. Gonçalves

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

8 Citas (Scopus)

Resumen

Aims: Treatment for visceral leishmaniasis (VL) is hampered by the toxicity and/or high cost of drugs, as well as by emergence of parasite resistance. Therefore, there is an urgent need for new antileishmanial agents. Methods and Results: In this study, the antileishmanial activity of a diprenylated flavonoid called 5,7,3,4’-tetrahydroxy-6,8-diprenylisoflavone (CMt) was tested against Leishmania infantum and L amazonensis species. Results showed that CMt presented selectivity index (SI) of 70.0 and 165.0 against L infantum and L amazonensis promastigotes, respectively, and of 181.9 and 397.8 against respective axenic amastigotes. Amphotericin B (AmpB) showed lower SI values of 9.1 and 11.1 against L infantum and L amazonensis promastigotes, respectively, and of 12.5 and 14.3 against amastigotes, respectively. CMt was effective in the treatment of infected macrophages and caused alterations in the parasite mitochondria. L infantum-infected mice treated with miltefosine, CMt alone or incorporated in polymeric micelles (CMt/Mic) presented significant reductions in the parasite load in distinct organs, when compared to the control groups. An antileishmanial Th1-type cellular and humoral immune response were developed one and 15 days after treatment, with CMt/Mic-treated mice presenting a better protective response. Conclusion: Our data suggest that CMt/Mic could be evaluated as a chemotherapeutic agent against VL.

Idioma originalInglés
Número de artículoe12784
PublicaciónParasite Immunology
Volumen42
N.º12
DOI
EstadoPublicada - dic. 2020

Huella

Profundice en los temas de investigación de 'Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis'. En conjunto forman una huella única.

Citar esto